Anja Haltner

12PUBLICATIONS
29CO-AUTHORS
Optical technologyMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 14, 2026
Matching-adjusted indirect comparison of acoltremon ophthalmic solution 0.003% and cyclosporine 0.05% ophthalmic emulsion for increased tear production in patients with dry eye disease.

|Jul 10, 2025
Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema.

Sarah Walsh, Anja Haltner, Meaghan Bartlett

|Mar 06, 2025
Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPC.

Elena Castro, Di Wang, Sarah Walsh

|Oct 19, 2024
Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer.

Elena Castro, Jenna Ellis, Samantha Craigie

|Oct 22, 2022
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.

Tom Martin, Saad Z Usmani, Jordan M Schecter

|Jul 11, 2022
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma.

Luciano J Costa, Parameswaran Hari, Jesus G Berdeja

Pageof 2

Frequent Collaborators

9 joint publications

Imtiaz A Samjoo

6 joint publications

Chris Cameron

3 joint publications

Evelyn Worthington

3 joint publications

Frank Dahlke